Skip to main content
Veterinary Medicines

T 61, Injekční roztok

Authorised
  • Embutramide
  • Mebezonium iodide
  • Tetracaine hydrochloride

Product identification

Medicine name:
T 61, Injekční roztok
Active substance:
  • Embutramide
  • Mebezonium iodide
  • Tetracaine hydrochloride
Target species:
  • All non-food producing species
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Embutramide
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Mebezonium iodide
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Tetracaine hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • All non-food producing species
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AX50
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/234/90-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."